 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FORT WORTH, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...

TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference   December 7, 2023

TFF Pharmaceuticals ( NASDAQ:TFFP ) Third Quarter 2023 Results Key Financial Results Net loss: US$4.41m (loss narrowed...

TFF Pharmaceuticals Third Quarter 2023 Earnings: Beats Expectations

Company remains on track to report initial data from TFF VORI and TFF TAC Phase 2 trials by the end of 2023 Conference call and webcast, today Tuesday November 14, 2023, at 4:30 pm ET to provide...

TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

TFF Pharmaceuticals publishes research on intranasal delivery of mAbs

Research shows the Company's Thin Film Freezing can reformulate broad range of monoclonal antibodies in combination with Aptar Pharma's Unidose (UDS) Powder Nasal Spray System for intranasal...

TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing

Algernon Pharmaceuticals (OTCMKTS:AGNPF  Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP  Get Free Report) are both medical companies, but which is the superior business? We will...

Algernon Pharmaceuticals (OTCMKTS:AGNPF) versus TFF Pharmaceuticals (NASDAQ:TFFP) Head-To-Head Contrast

FORT WORTH, Texas, Oct. 02, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...

TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines

FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

FORT WORTH, Texas, Aug. 23, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...

TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference   September 11-13, 2023

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP  Get Free Report) major shareholder Carlson Capital L. P sold 215,000 shares of the businesss stock in a transaction dated Tuesday, August 15th...

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Major Shareholder Sells $94,600.00 in Stock

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.

Watchers	1,808
52-Wk Low	$0.2058
52-Wk High	$1.33

Market Cap	$18.04M
Volume (M)	98,140.00
52-Wk High	$1.33
52-Wk Low	$0.2058

TFFP Tff Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals